The benchmark indices settled 0.5 per cent higher on Monday led by market heavyweights Reliance Industries, Sun Pharma and select information technology (IT) and private bank stocks.
The S&P BSE Sensex ended at 36,579, up 192 points or 0.53 per cent, while the broader Nifty50 index settled at 10,962, up 55 points or 0.50 per cent.
Among sectoral indices, the Nifty Pharma index was the top gainer, rising 0.52 per cent higher led by Sun Pharmaceutical Industries and Biocon. The Nifty IT index, too, rose 0.49 per cent led by Infosys and NIIT Technologies.
In the broader market, S&P BSE MidCap index slipped 84 points or 0.56 per cent to settle at 14,939, while S&P BSE SmallCap index ended at 14,402, down 102 points or 0.70 per cent.
Shares of Reliance Industries (RIL) rose 4.36 per cent to end the day at Rs 1,234.50 apiece on Monday. The stock gained nine per cent in the past two trading days on BSE, after the company reported a better-than-expected consolidated net profit of Rs 10,251 crore in October-December quarter (Q3FY19). The company had logged profit of Rs 9,420 crore in the year-ago quarter.
Shares of Sun Pharmaceutical Industries gained 1.94 per cent to settle at Rs 398.35 apiece on the BSE on Monday, after the pharmaceutical firm urged markets regulator Sebi to examine the role of some media houses with respect to the reports of fresh whistleblower complaints.
Asian markets kept their nerve on Monday as data showed the Chinese economy slowed at the end of last year, underlining the urgent need for more stimulus as Beijing wrestles with the United States over trade.
Markets reacted calmly, with MSCI’s broadest index of Asia-Pacific shares outside Japan up 0.2 per cent, after rising 1.6 per cent last week. Chinese blue chips gained 0.7 per cent. Japan's Nikkei added 0.3 per cent, helped by a recent pullback in the yen.
(with Reuters input)